Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,621.04 104.77 0.72%
TOPIX 1,179.32 5.95 0.51%
HANG SENG 22,760.24 64.23 0.28%

Biodel to Report Second Quarter Fiscal Year 2013 Financial Results on May 8, 2013



Biodel to Report Second Quarter Fiscal Year 2013 Financial Results on May 8,
2013

DANBURY, Conn., May 6, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) will
issue its second quarter fiscal year 2013 financial results on May 8, 2013.
Following the release of the company's financial results, Biodel's senior
management will host a conference call to discuss the results and provide an
update on the company's progress.

May 8, 2013 schedule:                                                      
               
7:30 a.m. ET: Second Quarter fiscal year 2013 results will be distributed
               
7:45 a.m. ET: Conference call participants should dial:
              +1 (877) 303-8028 (United States) or
              +1 (760) 536-5167 (International)
               
8:00 a.m. ET: Conference call begins

Interested parties may access a live audio webcast of the conference call in
the investor section of Biodel's website at www.biodel.com. The audio webcast
will be archived and available for replay through the website. Interested
parties may also access an audio replay by dialing (855) 859-2056 (US) or
(404) 537-3406 (International) and entering conference ID number 57651588.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the
development and commercialization of innovative treatments for diabetes that
may be safer, more effective and more convenient for patients. We develop our
product candidates by applying our proprietary formulation technologies to
existing drugs in order to improve their therapeutic profiles.

BIOD-G

CONTACT: Seth D. Lewis, +1-646-378-2952
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement